Clinical Trial Update: Low Antimonial Dosage in American Mucosal Leishmaniasis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update from Fiocruz investigates using a lower dosage of antimonial treatment for American mucosal leishmaniasis, spanning Phase 2 and Phase 3,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucocutaneous Leishmaniasis
• Mucosal Leishmaniasis

Drugs mentioned

• Meglumine antimoniate (meglumine antimoniate)
• Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: Oswaldo Cruz Foundation | Conditions: Mucosal Leishmaniasis, Mucocutaneous Leishmaniasis | Phase 2, Phase 3 | Status: UNKNOWN